Literature DB >> 7153847

Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro.

T Irie, M Otagiri, M Sunada, K Uekama, Y Ohtani, Y Yamada, Y Sugiyama.   

Abstract

Cyclodextrins (CyDs) at higher concentrations were found to cause hemolysis of human erythrocytes in the order of beta- greater than alpha- greater than gamma-CyD in isotonic solution. Biphasic effects of CyDs were observed for the osmotic and heat-induced hemolysis; i.e. the protection at relatively low CyD concentrations and stimulation at higher CyD concentrations. From the scanning electron microscopic observations, CyDs induced shape changes of membrane internalization type on erythrocytes. CyDs caused the release of cholesterol from erythrocyte membrane in the order of beta- greater than gamma- greater than alpha-CyD. These results clearly indicate that CyD-induced hemolysis is probably a secondary event resulting from the membrane disruption which elicited the removal of membrane components from erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153847     DOI: 10.1248/bpb1978.5.741

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  29 in total

1.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

2.  Molecular dynamics study of an alpha-cyclodextrin-phosphatidylinositol inclusion complex.

Authors:  M Göschl; S Crouzy; Y Chapron
Journal:  Eur Biophys J       Date:  1996       Impact factor: 1.733

3.  The effect of parenterally administered cyclodextrins on cholesterol levels in the rat.

Authors:  H W Frijlink; A C Eissens; N R Hefting; K Poelstra; C F Lerk; D K Meijer
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

4.  NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS.

Authors:  Mingnan Chen; Jonathan R McDaniel; J Andrew Mackay; Ashutosh Chilkoti
Journal:  Technol Innov       Date:  2011-01-01

5.  Characteristics of pyrene phospholipid/gamma-cyclodextrin complex.

Authors:  K Tanhuanpää; K H Cheng; K Anttonen; J A Virtanen; P Somerharju
Journal:  Biophys J       Date:  2001-09       Impact factor: 4.033

Review 6.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06

7.  The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

Authors:  W J Irwin; A K Dwivedi; P A Holbrook; M J Dey
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

8.  Cyclodextrins as carriers of cholesterol and fatty acids in cultivation of mycoplasmas.

Authors:  N Greenberg-Ofrath; Y Terespolosky; I Kahane; R Bar
Journal:  Appl Environ Microbiol       Date:  1993-02       Impact factor: 4.792

9.  Bacterial toxicity of cyclodextrins: luminuous Escherichia coli as a model.

Authors:  R Bar; S Ulitzur
Journal:  Appl Microbiol Biotechnol       Date:  1994-07       Impact factor: 4.813

10.  Differential effects of sulfate and sulfobutyl ether of beta-cyclodextrin on erythrocyte membranes in vitro.

Authors:  K Shiotani; K Uehata; T Irie; K Uekama; D O Thompson; V J Stella
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.